3175 results for «505»
3175 results
CT analysis - Be ready for our LIVE Educational cases on TAVI
11 Sep 2025 – From PCR Rio Valves 2025
Prepare for live educational cases on transcatheter aortic valve implantation (TAVI) by mastering CT analysis techniques. This session guides you through obtaining and measuring the aortic annulus, interpreting the crucial aortic annulus S-curve, and understanding the views necessary along this curve for successful TAVI procedures.
Watch related...
Mastering tricuspid TEER - LIVE Case
12 Sep 2025 – From PCR Rio Valves 2025
A 77-year-old male with atrial fibrillation and chronic kidney disease presented with symptomatic severe atrial tricuspid regurgitation.He underwent implantation of two TriClip XTW devices (antero-septal and postero-septal) under general anesthesia, guided by transesophageal echocardiography (TEE).
LIVE Educational Case from Bordeaux University Hospital - Bordeaux, France
Navigate the video...
How to optimise outcome in valve-in-valve and valve-in-mitral annular calcification patients
12 Sep 2025 – From PCR Rio Valves 2025
This session explores how to optimise outcomes in valve-in-valve and valve-in-mitral annular calcification procedures. Clinical evidence is combined with real case demonstrations, highlighting step-by-step approaches, practical strategies, and techniques to reduce risks such as left ventricular outflow tract obstruction in high-risk patients.
Redo TAVI
12 Sep 2025 – From PCR Rio Valves 2025
This session focuses on the challenges and strategies of redo TAVI, from careful planning to valve selection and tailored procedural approaches. Learn how to manage different valve platforms, optimise outcomes in valve-in-valve scenarios, and prevent complications such as coronary obstruction through real case discussions.
Expanding horizons with balloon-expandable TAVI - LIVE Case
12 Sep 2025 – From PCR Rio Valves 2025
A 76-year-old male with a history of abdominal and iliac stent grafts (2022), severe COPD, prostate cancer, and gastric ulcer presented with symptomatic severe aortic stenosis. CT and echocardiography showed a calcified bicuspid aortic valve with preserved LV function.
A 24.5 mm Myval valve was implanted without...
TAVI in challenging scenarios, diving into real-life cases
12 Sep 2025 – From PCR Rio Valves 2025
Navigate the complexities of challenging TAVI cases through real-life clinical scenarios. This session offers valuable insights into managing complications such as aortic regurgitation, bicuspid valves, valve-in-valve procedures, coronary obstruction, and large annulus with left ventricular outflow tract calcification. Participants will gain practical tips and tricks to...
Orthotopic mitral devices coming soon
12 Sep 2025 – From PCR Rio Valves 2025
This session provides a forward-looking perspective on emerging orthotopic mitral valve devices for repair and replacement. Discussions focus on new device technologies soon to be available, patient selection criteria, and the specific developmental challenges encountered. Case presentations, including the TVMR Intrepid system, illustrate clinical applications and...
Management of residual and recurrent mitral regurgitation after TEER
12 Sep 2025 – From PCR Rio Valves 2025
Delve into the complexities of managing residual and recurrent mitral regurgitation following Transcatheter Edge-to-Edge Repair (TEER). This session discusses challenges such as late mitral regurgitation, strategies for handling single leaflet detachment, and anatomical considerations that may preclude TEER feasibility.
Integrating the newest valve guidelines into daily clinical reality
12 Sep 2025 – From PCR Rio Valves 2025
Integrate the 2025 EACTS valve guidelines into your clinical practice with a focus on valvular heart disease management tailored to Latin American realities. This session reviews the most relevant updates on aortic stenosis management and transcatheter approaches for mitral and tricuspid valves.
Watch the interview with Fabien...
TAVI - Take the first step considering life time management
12 Sep 2025 – From PCR Rio Valves 2025
Understand the critical importance of lifetime management in TAVI, emphasizing how the initial procedure impacts long-term results. This session discusses implantation depth, commissural alignment, and their roles beyond coronary access, illustrated through a low-risk young patient case and current durability data.
Precision in mitral TEER
11 Sep 2025 – From PCR Rio Valves 2025
Join this live educational session from Bordeaux University Hospital to gain expert insights into mitral transcatheter edge-to-edge repair (TEER). Explore optimal timing and clinical decision-making for mitral regurgitation treatment, and discover how the PASCAL Precision system enhances procedural precision across diverse mitral anatomies. Witness real-time strategies,...
Continued global expansion of Stent – Save a Life!
18 May 2023
There is no doubt that the original Stent for Life initiative had a huge, positive impact on morbidity and mortality in patients with STEMI in Europe. With the global Stent – Save a Life! (SSL) initiative comes the continued spread of the mission to other regions,...
RESHAPE-HF2 - Percutaneous repair of moderate-to-severe or severe functional mitral regurgitation in patients with symptomatic heart failure
01 Sep 2024
Nicola Ryan provides her take on the RESHAPE-HF2 trial presented by Stefan Anker at the ESC Congress 2024 in London and simultaneously published in the NEJM.
The RESHAPE-HF 2 trial is a prospective randomised control trial comparing transcatheter mitral valve repair (TEER) and guideline-directed medical therapy to guideline-directed medical...
Author
DAPT-SHOCK-AMI trial: Cangrelor in cardiogenic shock
03 Sep 2025
Kalaivani Mahadevan and Fizzah Choudry provide their take on DAPT-SHOCK-MI presented by Zuzana Motovska at ESC Congress 2025 in Madrid.
Author
Author
Intravascular ultrasound-guided versus angiography-guided percutaneous coronary intervention in acute coronary syndromes: The multicenter, randomized, blinded, IVUS-ACS Trial
09 Apr 2024
Marco Spagnolo and Daniele Giacoppo report the main results of the IVUS-ACS trial presented by Shao-Liang Chen, from the Nanjing First Hospital, Nanjing Medical University, Nanjing, in a Featured Clinical Research session at ACC.24 in Atlanta and simultaneously published in The Lancet.(1)
Author
Author
